RNase 8 activators encompass a variety of chemical compounds that function through distinct biochemical mechanisms to enhance the activity of this enzyme. Certain activators operate by elevating intracellular levels of cyclic adenosine monophosphate (cAMP), a pivotal second messenger in multiple signaling pathways that can influence phosphorylation states and the functional regulation of various proteins. This increase in cAMP can be achieved by directly stimulating adenylate cyclase, thereby enhancing the production of cAMP, or by inhibiting phosphodiesterases, which are responsible for cAMP degradation. As cAMP levels rise, protein kinases are activated, which may then phosphorylate proteins involved in the regulation of RNase 8, leading to its enhanced activity. Furthermore, some activators modulate calcium signaling pathways by increasing intracellular calcium concentrations. This can be achieved via calcium ionophores or by the activation of L-type calcium channels, subsequently triggering calcium-dependent protein kinases that could play a role in upregulating RNase 8 activity.
Additionally, certain compounds activate protein kinase C (PKC) which is involved in various cellular processes, including the regulation of protein function through phosphorylation. Activation of PKC could modulate the activity of proteins that are part of the regulatory network of RNase 8. The modulation of intracellular calcium levels by activators also exerts an effect on calcium-sensitive signaling cascades, potentially leading to alterations in protein interactions and activities that can influence RNase 8.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
This diterpene activates adenylate cyclase, increasing cAMP levels, which in turn can enhance RNase 8 activity by promoting the phosphorylation of proteins involved in its regulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
By activating protein kinase C (PKC), it modulates phosphorylation states of proteins that can lead to the activation of RNase 8. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
This ionophore increases intracellular calcium levels, which can activate calcium-dependent protein kinases that may indirectly increase RNase 8 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
As a calcium ionophore, it raises intracellular calcium levels, potentially activating pathways that upregulate RNase 8 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A beta-adrenergic agonist that elevates cAMP levels, possibly resulting in the activation of proteins that regulate RNase 8. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
This selective phosphodiesterase-4 inhibitor prevents cAMP breakdown, potentially enhancing signaling pathways that activate RNase 8. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
A non-selective phosphodiesterase inhibitor that prevents cAMP degradation, possibly leading to increased RNase 8 activity through elevated intracellular cAMP levels. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $81.00 | 1 | |
An L-type calcium channel activator that increases calcium influx, possibly leading to the activation of calcium-dependent kinases that enhance RNase 8 activity. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
This dihydropyridine L-type calcium channel agonist may increase calcium influx, indirectly leading to the activation of RNase 8. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
A phosphodiesterase inhibitor with specificity for PDE5, which could increase cAMP and/or cGMP levels, potentially leading to the activation of pathways regulating RNase 8. |